Aeglea BioTherapeutics Earning Date (AGLE)

USA |NASDAQ |USD

AGLE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 16, 2022 Dec 2021 $-0.29 $-0.31 $-0.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 16, 2022 Dec 2021 $2.46M $1.40M $0.00

Aeglea Biotherapeutics's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 2021.

AGLE Earnings Date & History Chart

AGLE Earnings & Revenue Forecast

AGLE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 4 $-0.33 $-0.36 $-0.30
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-0.97 $-1.57 $0.56

AGLE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.33 $-0.33 $-0.33
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.97 $-0.96 $-0.96

AGLE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 2 $700.00K $0.00 $1.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $7.58M $0.00 $27.30M

AGLE Earnings Date & Revenue History

AGLE Earnings History

|
Show More
Show More

AGLE Revenue History

|
Show More
Show More

Aeglea Biotherapeutics Next Earnings Date & Report

AGLE Next Earnings Date & Report Preview: Dec 2021 (FQ)

AGLE's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 7 analysts, the average EPS estimation for Aeglea Biotherapeutics's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.34, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.29, the last 2 month trend is $-0.31, and the 3 month trend is $-0.31.

Based on 5 analysts, the average revenue estimation is $2.46M, with a low revenue estimation of $0.00, and a high estimation of $9.50M.

Aeglea Biotherapeutics Previous Earnings Dates & Reports

AGLE Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aeglea Biotherapeutics's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

AGLE's earnings per share (EPS) was $-0.31, missing the consensus analysts forecast of $-0.29 by -5.62%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 210.00%, and lower than the same period a year before (Sep 2020) by 6.90%.

Revenues were $1.40M.

The company reported a net income of $-20.31M.

Free cash flow for the quarter was $-17.09M , compared to $2.05M last quarter and $-18.10M a year before.

AGLE ended the quarter with $5.16M in total debt, a decrease of -2.48% compared to the previous quarter, and a decrease of -2.40% compared to the same quarter a year before.

AGLE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aeglea Biotherapeutics's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.

AGLE's earnings per share (EPS) was $-1.60, missing the consensus analysts forecast of $-1.50 by 6.67% , and higher than the previous year's EPS (Dec 2019) by -34.69%.

Revenues were $21.84K.

The company reported a net income of $-80.89M.

Aeglea Biotherapeutics reported a free cash flow of $-80.06M for its fiscal year, compared to $-67.18M a year ago.

The company ended the fiscal year with $5.45M in total debt, an increase of 7.60% compared to the previous year.